Site Members can sign up for company wide alerts
Investigation Overview
After Novartis announced that the Genoptix board of directors agreed to a buyout offer of $25 per share an investigation for investors of Genoptix, Inc. (NASDAQ:GXDX) over possible breaches of fiduciary duty was announced within hours. The investigation by a law firm concerns whether certain directors and officers at Genoptix, Inc. (NASDAQ:GXDX) will breach their fiduciary duties in t...
You must register (for free) or login to view the entire investigation.